To gain a better understanding of the company, its product portfolio and its management team, BioAlliance Pharma organizes a symposium "Oncology: key issues for the future" (PDF - 205 Ko)
2011 achievements and 2012 prospects - BioAlliance Pharma confirms the dynamics of its core business (PDF - 360 Ko)
BioAlliance Pharma announces two key steps with its AMEP™ biotherapy for metastatic melanoma (PDF - 385 Ko)
BioAlliance Pharma: New achievements in the collaboration with its strategic European partner, Therabel (PDF - 281 Ko)